Trial Profile
Clinical Trials Insight: 700029122
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2007
Price :
$35
*
At a glance
- Drugs Anti-interleukin-6 monoclonal antibody (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Regeneron Pharmaceuticals; Sanofi
- 06 Dec 2007 New trial record.